doi:10.3969/j.issn.1673-8640.2020.01.017

Abstract

CLC Number:

R446.1

Figures/Tables 3

References 10

[1]	SIRCAR M,THADHANI R,KARUMANCHI S A.Pathogenesis of preeclampsia[J]. Curr Opin Nephrol Hypertens,2015,24(2):131-138.
[2]	HARMON A C,CORNELIUS D C,AMARAL L M,et al.The role of inflammation in the pathology of preeclampsia[J]. Clin Sci(Lond),2016,130(6):409-419.
[3]	CHEN Y,LIN L.Potential value of coagulation parameters for suggesting preeclampsia during the third trimester of pregnancy[J]. Am J Med Sci,2017,354(1):39-43.
[4]	谢幸,苟文丽,林仲秋. 妇产科学[M]. 8版. 北京:人民卫生出版社,2014:92-105.
[5]	LIBERIS A,STANULOV G,ALI E C,et al.Pre-eclampsia and the vascular endothelial growth factor:a new aspect[J]. Clin Exp Obstet Gynecol,2016,43(1):9-13.
[6]	SUN L,YE R D.Serum amyloid A1:structure,function and gene polymorphism[J]. Gene,2016,583(1):48-57.
[7]	MOHAUPT M G.C-reactive protein and its role in preeclampsia[J]. Hypertension,2015,65(2):285-286.
[8]	UCKAN K,SAHIN H G.Serum amyloid A,procalcitonin,highly sensitive C reactive protein and tumor necrosis factor alpha levels and acute inflammatory response in patients with hemolysis,elevated liver enzymes,low platelet count(HELLP) and eclampsia[J]. J Obstet Gynaecol Res,2018,44(3):440-447.
[9]	MENON R,JONES J,GUNST P R,et al.Amniotic fluid metabolomic analysis in spontaneous preterm birth[J]. Reprod Sci,2014,21(6):791-803.
[10]	USTÜN Y,ENGIN-USTÜN Y,KAMACI M. Association of fibrinogen and C-reactive protein with severity of preeclampsia[J]. Eur J Obstet Gynecol Reprod Biol,2005,121(2):154-158.

组别	SAA/（mg/L）	Fib/（g/L）
子痫前期重度组	55.58±16.03*#	5.27±0.91*#
子痫前期轻度组	23.25±7.81^*	4.23±0.84^*
对照组	17.00±5.27	3.53±0.85
F值	109.44	17.48
P值	<0.001	<0.001

组别	SAA/（mg/L）	Fib/（g/L）
子痫前期重度组	55.58±16.03*#	5.27±0.91*#
子痫前期轻度组	23.25±7.81^*	4.23±0.84^*
对照组	17.00±5.27	3.53±0.85
F值	109.44	17.48
P值	<0.001	<0.001

项目	AUC（95%CI）	敏感性/%	特异性/%
SAA	0.865（0.782~0.925）	83.33	81.82
Fib	0.846（0.760~0.911）	69.70	87.88
Fib+SAA	0.930（0.860~0.971）	75.76	96.97

项目	AUC（95%CI）	敏感性/%	特异性/%
SAA	0.865（0.782~0.925）	83.33	81.82
Fib	0.846（0.760~0.911）	69.70	87.88
Fib+SAA	0.930（0.860~0.971）	75.76	96.97

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 3

References 10

Related Articles 15

Recommended Articles

Metrics